세계의 일회용 어셈블리 시장(-2029년) : 제품별(백(2D, 3D), 여과, 보틀, 믹싱, 튜브 어셈블리), 솔루션별(맞춤형, 표준), 모달리티별(mAb, 백신, CGT), 용도별(여과, 세포배양, 보관, 이송)

The single-use assemblies market is expected to grow to USD 4.89 billion by 2029, up from USD 2.63 billion in 2024, at a CAGR of 13.2% between 2024 and 2029. Growth in this market is mainly driven by the growing adoption among CDMOs, SMEs & startups, rapid implementation and low risk of cross-contamination, growing biologics & biosimilar markets, and cost savings with single-use assemblies. Furthermore, there is a growing focus on technological developments and outsourcing services. Furthermore, emerging countries provide significant development opportunities, and the focus on capacity expansion by biopharmaceutical companies is expected to drive the market further.

"The 2D bag assemblies segment accounted for the largest share of bag assemblies segment for the single-use assemblies market in 2023."

The bag assemblies segment of the single-use assemblies market is further divided into 2D & 3D bag assemblies. In 2023, the 2D bag assemblies segment accounted for the largest share of the global single-use assemblies market by bag assemblies. The dominance of 2D bag assemblies over 3D assemblies can be attributed to their simpler design, ease of handling, and suitability for lower-volume operations. Additionally, their ability to integrate seamlessly into automated systems and compatibility with a range of fluids, such as buffers and reagents, makes them a preferred choice for manufacturers.

"The monoclonal antibodies segment accounted for the largest share of by modalities segment for the single-use assemblies market in 2023."

In 2023, the monoclonal antibodies segment accounted for the largest share of the global single-use assemblies market by modality. Monoclonal antibodies (mAbs) are one of the largest segments of the biotechnology drugs market. Factors The large share of the monoclonal antibodies (mAbs) segment can be attributed to the increasing demand for single-use assemblies in the manufacturing of mAbs due to low capital investment, low workforce requirements, and reductions in time-consuming changeover procedures and validation.

"In 2023, the US remained to dominate the single-use assemblies market."

The US dominated the North American single-use assemblies market in 2023. The US is the world's largest biopharmaceutical market and the leader in biopharmaceutical research and investment. The United States also has a strong healthcare infrastructure, which encourages research and development in the life sciences. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, the growing support from government bodies in the form of funds and grants is also driving the growth of the single-use assemblies market.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other

executives from various key organizations operating in the single-use assemblies

marketplace.

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
• By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

Thermo Fisher Scientific Inc. (US); Sartorius AG (Germany); Danaher Corporation (US); Merck KGaA (Germany); Avantor, Inc. (US); are some of the key players in the single-use assemblies market.

The study includes an in-depth competitive analysis of these key players in the single-use assemblies market, with their company profiles, recent developments, and key market strategies

Research Coverage:

This research report categorizes the single-use assemblies market by product ( bag assemblies {2D bag assemblies and 3D bag assemblies}, filtration assemblies, bottle assemblies, tubing assemblies, mixing assemblies, sampling assemblies, sensor assemblies, and other single-use assembly products), solution (standard solutions and customized solutions), modality (monoclonal antibodies, vaccines, therapeutic proteins & peptides, and cell & gene therapies), application (filtration & purification applications, aseptic transfer, storage applications, sampling applications, cell culture, formulation & fill-finish applications, and mixing), end user (pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-use assemblies market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the single-use assemblies market.

Reasons to buy this report

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall single-use assemblies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (rising adoption of single-use assemblies in biopharmaceutical manufacturing, increasing focus on advantages of single-use solutions over traditional bioprocessing, booming biologics and biosimilars market, and growing advancements in single-use assembly technologies), restraints (issues related to leachables and extractables, complex and stringent regulatory landscape for single-use products, leakage and integrity issues), opportunities (high growth in emerging economies, rising focus on expanding bioprocessing capacities), and Challenges (standardization of single-use assemblies, waste generation and disposal issues, gap between demand and supply of single-use assemblies) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the single-use assemblies market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-use assemblies market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like Thermo Fisher Scientific Inc (US), Sartorius AG (Germany), Merck KGaA (Germany), Danaher Corporation (US), Avantor, Inc. (US), Parker Hannifin Corporation (US), Saint-Gobain (France), Repligen Corporation (US), Corning Incorporated (US), Entegris (US), among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET ESTIMATION METHODOLOGY
  • 2.2.1 MARKET ESTIMATION
  • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
  • 2.2.3 TOP-DOWN APPROACH
• 2.3 MARKET GROWTH RATE PROJECTION
• 2.4 DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SINGLE-USE ASSEMBLIES MARKET OVERVIEW
• 4.2 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY APPLICATION AND COUNTRY, 2023
• 4.3 SINGLE-USE ASSEMBLIES MARKET, BY END USER, 2024 VS. 2029
• 4.4 SINGLE-USE ASSEMBLIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising adoption of single-use systems in biopharmaceutical manufacturing
    • 5.2.1.2 Increasing focus on advantages of single-use solutions over traditional bioprocessing
    • 5.2.1.3 Booming biologics and biosimilars market
    • 5.2.1.4 Growing advancements in single-use assembly technologies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Issues related to leachables and extractables
    • 5.2.2.2 Complex and stringent regulatory landscape for single-use products
    • 5.2.2.3 Leakage and integrity issues
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 High growth in emerging economies
    • 5.2.3.2 Rising focus on expanding bioprocessing capacities
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Standardization of single-use assemblies
    • 5.2.4.2 Waste generation and disposal issues
    • 5.2.4.3 Gap between demand and supply of single-use assemblies
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
  • 5.7.1 RAW MATERIAL SUPPLIERS
  • 5.7.2 PRODUCT MANUFACTURERS
  • 5.7.3 END USERS
  • 5.7.4 REGULATORY BODIES
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Filtration
    • 5.9.1.2 Cell culture
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
  • 5.9.3 ADJACENT TECHNOLOGIES
• 5.10 PATENT ANALYSIS
• 5.11 TRADE ANALYSIS
  • 5.11.1 IMPORT DATA FOR HS CODE 392390
  • 5.11.2 EXPORT DATA FOR HS CODE 392390
• 5.12 KEY CONFERENCES AND EVENTS
• 5.13 REGULATORY LANDSCAPE
  • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13.2 REGULATORY FRAMEWORK
    • 5.13.2.1 North America
      • 5.13.2.1.1 US
      • 5.13.2.1.2 Canada
    • 5.13.2.2 Europe
      • 5.13.2.2.1 Germany
      • 5.13.2.2.2 UK
    • 5.13.2.3 Asia Pacific
      • 5.13.2.3.1 Japan
      • 5.13.2.3.2 China
    • 5.13.2.4 Latin America
      • 5.13.2.4.1 Brazil
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 THREAT OF NEW ENTRANTS
  • 5.14.2 THREAT OF SUBSTITUTES
  • 5.14.3 BARGAINING POWER OF BUYERS
  • 5.14.4 BARGAINING POWER OF SUPPLIERS
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.15.2 BUYING CRITERIA
• 5.16 IMPACT OF AI/GENERATIVE AI ON SINGLE-USE ASSEMBLIES MARKET
  • 5.16.1 INTRODUCTION
  • 5.16.2 MARKET POTENTIAL FOR SINGLE-USE ASSEMBLIES
  • 5.16.3 AI USE CASES
  • 5.16.4 KEY COMPANIES IMPLEMENTING AI
  • 5.16.5 FUTURE OF GENERATIVE AI ON SINGLE-USE ASSEMBLIES ECOSYSTEM

6 SINGLE-USE ASSEMBLIES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 BAG ASSEMBLIES
  • 6.2.1 2D BAG ASSEMBLIES
    • 6.2.1.1 Growing use in buffer preparation, media storage, and harvest collection to fuel market
  • 6.2.2 3D BAG ASSEMBLIES
    • 6.2.2.1 Larger volume storage and transport capabilities to speed up growth
  • 6.2.3 BAG ASSEMBLIES, BY APPLICATION
• 6.3 FILTRATION ASSEMBLIES
  • 6.3.1 RISING FOCUS ON PREVENTING LOSSES AND MAINTAINING PRODUCT QUALITY TO BOOST MARKET
• 6.4 BOTTLE ASSEMBLIES
  • 6.4.1 REDUCED DOWNTIME AND TURNAROUND TIME TO BOOST MARKET
  • 6.4.2 BOTTLE ASSEMBLIES, BY APPLICATION
• 6.5 TUBING ASSEMBLIES
  • 6.5.1 ENHANCED RISK MANAGEMENT AND PRODUCTION TO ENCOURAGE GROWTH
• 6.6 MIXING ASSEMBLIES
  • 6.6.1 MINIMIZED OPERATOR EXPOSURE AND REDUCED DOWNTIME FOR CLEANING TO AID GROWTH
• 6.7 SAMPLING ASSEMBLIES
  • 6.7.1 NEED FOR QUALITY CONTROL AND PROCESS MONITORING IN BIOPROCESSING TO AUGMENT GROWTH
• 6.8 SENSOR ASSEMBLIES
  • 6.8.1 GROWING ADOPTION OF BIOPROCESSING AUTOMATION TO DRIVE MARKET
• 6.9 OTHER SINGLE-USE ASSEMBLY PRODUCTS

7 SINGLE-USE ASSEMBLIES MARKET, BY SOLUTION

• 7.1 INTRODUCTION
• 7.2 STANDARD SOLUTIONS
  • 7.2.1 GROWING FOCUS ON CAPITAL COST AND OPERATIONAL FLEXIBILITY TO DRIVE MARKET
• 7.3 CUSTOMIZED SOLUTIONS
  • 7.3.1 NEED FOR ENHANCED PROCESS EFFICIENCY IN BIOPHARMACEUTICAL MANUFACTURING TO PROMOTE GROWTH

8 SINGLE-USE ASSEMBLIES MARKET, BY MODALITY

• 8.1 INTRODUCTION
• 8.2 MONOCLONAL ANTIBODIES
  • 8.2.1 INCREASING POPULARITY OF TARGETED THERAPY TO PROMOTE GROWTH
• 8.3 VACCINES
  • 8.3.1 ONGOING NEED TO ADDRESS GLOBAL HEALTH CHALLENGES TO AUGMENT GROWTH
• 8.4 THERAPEUTIC PROTEINS & PEPTIDES
  • 8.4.1 GROWING SHIFT TOWARD BIOLOGIC TREATMENTS AND PERSONALIZED MEDICINES TO BOOST MARKET
• 8.5 CELL & GENE THERAPIES
  • 8.5.1 RISING R&D INITIATIVES AND COLLABORATIONS AMONG KEY PLAYERS TO FACILITATE GROWTH

9 SINGLE-USE ASSEMBLIES MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 FILTRATION & PURIFICATION APPLICATIONS
  • 9.2.1 INCREASING FOCUS ON MANUFACTURING AFFORDABLE BIOPHARMACEUTICALS TO SPUR GROWTH
• 9.3 ASEPTIC TRANSFER
  • 9.3.1 GROWING DEMAND FOR BIOLOGICS AND CELL & GENE THERAPIES TO FUEL MARKET
• 9.4 STORAGE APPLICATIONS
  • 9.4.1 NEED FOR FLEXIBLE AND SCALABLE STORAGE OPTIONS TO CONTRIBUTE TO GROWTH
• 9.5 SAMPLING APPLICATIONS
  • 9.5.1 INCREASING COMPLEXITY IN BIOLOGICS MANUFACTURING TO ENCOURAGE GROWTH
• 9.6 CELL CULTURE
  • 9.6.1 GROWING INVESTMENTS IN SINGLE-USE BIOPROCESSING INFRASTRUCTURE TO BOOST MARKET
• 9.7 FORMULATION & FILL-FINISH APPLICATIONS
  • 9.7.1 GROWING TREND OF OUTSOURCING TO PROPEL MARKET
• 9.8 MIXING APPLICATIONS
  • 9.8.1 PRE-STERILIZED DESIGN AND AUTOMATED DESIGNS TO ACCELERATE GROWTH

10 SINGLE-USE ASSEMBLIES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
  • 10.2.1 RISING PRODUCTION OF BIOLOGICS AND BIOSIMILARS TO SUSTAIN GROWTH
• 10.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
  • 10.3.1 GROWING PREFERENCE FOR OUTSOURCING RESEARCH AND MANUFACTURING ACTIVITIES TO STIMULATE GROWTH
• 10.4 ACADEMIC & RESEARCH INSTITUTES
  • 10.4.1 INCREASING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO FUEL MARKET

11 SINGLE-USE ASSEMBLIES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Highly advanced infrastructure and private funding to facilitate growth
  • 11.2.3 CANADA
    • 11.2.3.1 Increasing government support for biologics manufacturing to expedite growth
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 High government R&D investment and facility expansions by key players to aid growth
  • 11.3.3 UK
    • 11.3.3.1 Increased production of novel therapies, devices, and diagnostics to stimulate growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Rising number of research collaborations and healthcare investments to sustain growth
  • 11.3.5 ITALY
    • 11.3.5.1 Increasing investment in advanced biomanufacturing facilities to spur growth
  • 11.3.6 SPAIN
    • 11.3.6.1 Increasing development of targeted therapies to contribute to growth
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 Low manufacturing costs and high investments in biotechnology sector to encourage growth
  • 11.4.3 SOUTH KOREA
    • 11.4.3.1 Evolving pharmaceutical manufacturing market to accelerate growth
  • 11.4.4 JAPAN
    • 11.4.4.1 Robust regulatory framework and technological expertise to favor growth
  • 11.4.5 INDIA
    • 11.4.5.1 Low labor cost and availability of skilled professionals to propel market
  • 11.4.6 AUSTRALIA
    • 11.4.6.1 Increased investments in clinical trials to augment growth
  • 11.4.7 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Increasing adoption of cell & gene therapies to promote growth
  • 11.5.3 MEXICO
    • 11.5.3.1 Growing foreign direct investments to boost market
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Saudi Arabia
      • 11.6.2.1.1 Growing investments in healthcare infrastructure and research to fuel market
    • 11.6.2.2 UAE
      • 11.6.2.2.1 Rising focus on developing life science products to support growth
    • 11.6.2.3 Rest of GCC countries
  • 11.6.3 REST OF MIDDLE EAST
• 11.7 AFRICA
  • 11.7.1 GROWING DEMAND FOR CRITICAL DRUGS TO DRIVE MARKET
  • 11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE-USE ASSEMBLIES MARKET
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Product footprint
    • 12.5.5.4 Solution footprint
    • 12.5.5.5 Application footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 12.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.7.1 FINANCIAL METRICS
  • 12.7.2 COMPANY VALUATION
• 12.8 BRAND/PRODUCT COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 THERMO FISHER SCIENTIFIC INC.
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches
      • 13.1.1.3.2 Deals
      • 13.1.1.3.3 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 SARTORIUS AG
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Deals
      • 13.1.2.3.2 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 MERCK KGAA
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches
      • 13.1.3.3.2 Deals
      • 13.1.3.3.3 Expansions
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 DANAHER CORPORATION
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches
      • 13.1.4.3.2 Deals
      • 13.1.4.3.3 Expansions
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Key strengths
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 AVANTOR, INC.
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
      • 13.1.5.3.2 Expansions
  • 13.1.6 PARKER HANNIFIN CORPORATION
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Expansions
  • 13.1.7 SAINT-GOBAIN
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches
      • 13.1.7.3.2 Deals
      • 13.1.7.3.3 Expansions
  • 13.1.8 REPLIGEN CORPORATION
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Deals
      • 13.1.8.3.2 Expansions
  • 13.1.9 CORNING INCORPORATED
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
  • 13.1.10 ENTEGRIS
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Expansions
  • 13.1.11 LONZA
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
  • 13.1.12 ZACROS CORPORATION
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Expansions
  • 13.1.13 W. L. GORE & ASSOCIATES, INC.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
• 13.2 OTHER PLAYERS
  • 13.2.1 NEWAGE INDUSTRIES
  • 13.2.2 WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
  • 13.2.3 COBETTER
  • 13.2.4 ANTYLIA SCIENTIFIC
  • 13.2.5 NUPORE FILTRATION SYSTEMS
  • 13.2.6 INTELLITECH, INC.
  • 13.2.7 MEISSNER FILTRATION PRODUCTS, INC.
  • 13.2.8 SANISURE
  • 13.2.9 SENTINEL PROCESS SYSTEMS INC.
  • 13.2.10 FLUID FLOW PRODUCTS, INC.
  • 13.2.11 DOVER CORPORATION
  • 13.2.12 KEOFITT A/S
  • 13.2.13 CELLEXUS
  • 13.2.14 FOXX LIFE SCIENCES
  • 13.2.15 TSE INDUSTRIES, INC.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS